// App-Quantinova.ai

: The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • Andreas Guenther

Principal Investigators

  • Ekaterina Krauss

  • Walter Klepetko

  • Philippe Bonniaud

  • Carlo Vancheri

  • Athol Wells

  • Jasmin Wagner

  • Bettina Paul

  • Ulrich Costabel

  • Maria Asuncion Nieto Barbero

  • Veronika Mueller

  • Martina Vasakova

  • Alberto Pesci

  • Matteo Sofia

  • Fotios Drakopanagiotakis

  • Werner Seeger

  • Bruno Crestani

Medical Centers

  • European IPF Registry & Biobank (eurIPFreg), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardiopulmonary System (ECCPS), AGAPLESION Lung Clinic Waldhof-Elgershausen, Giessen, Germany

  • European IPF Registry & Biobank (eurIPFreg), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardiopulmonary System (ECCPS), AGAPLESION Lung Clinic Waldhof-Elgershausen, Giessen, Germany

  • University Hospital, Vienna, Austria

  • Departement de Pathologie, Centre Hospitalier Universitaire, Strasbourg, France

  • Dept. of Clinical and Molecular Biomedicine, Università degli Studi di Catania, Catania, Italy

  • Interstitial Lung Disease Unit, Royal Brompton Hospital, London, UK

  • University Hospital of Essen, Essen, Germany

  • Department of Pulmonology, Semmelweis University, Budapest, Hungary

  • General Teaching Hospital in Prague, Prague, Czech Republic

  • Ospedale S Gerardo, Monza, Italy

  • Ematologia,, Universit degli Studi di Napoli Federico II, Napoli, Italy

  • European IPF Registry & Biobank (eurIPFreg), Klinikum Fulda, Fulda, Germany

  • European IPF Registry & Biobank (eurIPFreg), Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Excellence Cluster Cardiopulmonary System (ECCPS), AGAPLESION Lung Clinic Waldhof-Elgershausen, Giessen, Germany

  • Competence Center for Rare Pulmonary Diseases, Hopital Bichat, Paris, France

Locations

  • Germany

  • Austria

  • France

  • Italy

  • United Kingdom

  • Spain

  • Hungary

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A